Qianwang Ma

机构：Second Hospital of Tianjin Medical University, Tianjin Medical University

发表论文 9 篇 · 总被引 169 次 · h-index 6

代表论文

• Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer (2020 · Journal of Cancer · 被引 48)
• Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer (2023 · Cell Death and Disease · 被引 39)
• Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets (2020 · npj Precision Oncology · 被引 39)
• Assessing the Potential Prognostic and Immunological Role of TK1 in Prostate Cancer (2022 · Frontiers in Genetics · 被引 15)
• Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3 (2021 · Journal of Cancer · 被引 10)
• A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy (2021 · Translational Andrology and Urology · 被引 9)